Company intelligence / Profile preview
Guangdong Shaxi Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Guangdong Shaxi Pharmaceutical is an established pharmaceutical company specializing in the development and manufacturing of traditional Chinese medicine tablets and herbal preparations. The company has developed quality control standards for its products and utilizes modern analytical techniques such as HPLC for ingredient determination[1]. It was acquired by Zhejiang Jingxin Pharmaceutical in 2021[3].
- Therapeutic areas
- RheumatologyOther
- Modalities
- Small moleculeTraditional Chinese medicine
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Guangdong Shaxi Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangdong Shaxi Pharmaceutical.